Legislative reports

The Oregon Prescription Drug Affordability Board is pleased to present the 2024 generic drug report for the Oregon Legislature in accordance with Senate Bill 844, the board's founding legislation. The report includes:

• Background, Page 4
  
• Authorized generics, Page 5
  
• Manufacturer strategies, Page 6
  
• Generic and biosimilar litigation, legislation, Page 9
  
• Generic and biosimilar drug pricing, Page 10
  
• Generics in other countries, Page 12
  
• Generic formulary placement, Page 13
  
• Generic drug shortages, Page 14
  
• Generic and biosimilar substitution, Page 16
  
• Conclusion, Page 17
  

View 2024 Generic Drug Report